Intranasal quetiapine abuse [6]

American Journal of Psychiatry

Volumn 161, Issue 9, 2004, Pages 1718-

  Pierre, Joseph M ^a   Shnayder, Igor ^a   Wirshing, Donna A ^a   Wirshing, William C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; QUETIAPINE; THIORIDAZINE; TRIHEXYPHENIDYL;

BEHAVIOR; DRUG ABUSE; DRUG INDICATION; DRUG SELF ADMINISTRATION; HOSPITAL ADMISSION; HUMAN; LETTER; PRESCRIPTION; PRIORITY JOURNAL; PRISON; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; SCHIZOPHRENIA; SIDE EFFECT; SUBSTANCE ABUSE;

EID: 4444260001     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.161.9.1718     Document Type: Letter

References (4)

1. Voruganti L, Cortese L, Oyewumi L, Cernovsky Z, Zirul S, Awad A: Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life. Schizophr Res 2000; 43:135-145
2. Pierre JM, Wirshing DA, Wirshing WC: "Iatrogenic malingering" in VA substance abuse treatment. Psychiatr Serv 2003; 54:253-254
3. Resnick PJ: The detection of malingered psychosis. Psychiatr Clin North Am 1999; 22:159-172
4. Buhrich N, Weller A, Kevans P: Misuse of anticholinergic drugs by people with serious mental illness. Psychiatr Serv 2000; 51: 928-929